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Background: Mycobacterium tuberculosis continues to kill more people than any other bacterium. Although its
archetypal host cell is the macrophage, it also enters, and survives within, dendritic cells (DCs). By modulating the
behaviour of the DC, M. tuberculosis is able to manipulate the host’s immune response and establish an infection.
To identify the M. tuberculosis genes required for survival within DCs we infected primary human DCs with an M.
tuberculosis transposon library and identified mutations with a reduced ability to survive.
Results: Parallel sequencing of the transposon inserts of the surviving mutants identified a large number of genes
as being required for optimal intracellular fitness in DCs. Loci whose mutation attenuated intracellular survival
included those involved in synthesising cell wall lipids, not only the well-established virulence factors, pDIM and
cord factor, but also sulfolipids and PGL, which have not previously been identified as having a direct virulence role
in cells. Other attenuated loci included the secretion systems ESX-1, ESX-2 and ESX-4, alongside many PPE genes,
implicating a role for ESX-5. In contrast the canonical ESAT-6 family of ESX substrates did not have intra-DC fitness
costs suggesting an alternative ESX-1 associated virulence mechanism. With the aid of a gene-nutrient interaction
model, metabolic processes such as cholesterol side chain catabolism, nitrate reductase and cysteine-methionine
metabolism were also identified as important for survival in DCs.
Conclusion: We conclude that many of the virulence factors required for survival in DC are shared with macrophages,
but that survival in DCs also requires several additional functions, such as cysteine-methionine metabolism, PGLs,
sulfolipids, ESX systems and PPE genes.
Keywords: Mycobacterium tuberculosis, dendritic cells, transposon library, cholesterol, phenolic glycolipids, sulfolipid,
phthiocerol dimycolates, ESX systems, nitrate reductase, PPE genesIntroduction
Mycobacterium tuberculosis is one of the world’s most
successful human pathogens, with almost 10 million new
cases every year [1] and more than 2 billion people latently
infected. People are usually infected with M. tuberculosis by
inhaling respired droplets that pass through the upper re-
spiratory tract and deposit the bacilli in the alveoli. Here
they are phagocytosed by a range of cells including neutro-
phils [2,3], macrophages [3] and dendritic cells (DCs) [3,4],* Correspondence: t.mendum@surrey.ac.uk
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sponse to the infection that is often protective. However in
some cases M. tuberculosis is able to manipulate both the
innate, and the subsequent adaptive immune response, to
establish an infection that may persist for a lifetime.
Although all these cells engulf M. tuberculosis into a
membrane bound phagosome, the fundamental functional
differences between them result in different phagosomal
environments and ultimately different outcomes for each
type of phagocyte. For example the neutrophil phagosome
remains relatively alkaline and generates a larger oxidative
burst [5] than that of macrophages. This is associated withal. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Mendum et al. BMC Genomics  (2015) 16:372 Page 2 of 14accelerated, necrotic neutrophil death and the signalling
of an inflammatory response that is capable of both acti-
vating macrophages and causing DCs to mature [6,7].
The primary host of M. tuberculosis is often consid-
ered to be the unactivated alveolar macrophage. M. tu-
berculosis is able to survive and proliferate in these cells
by inhibiting the bactericidal processes of phagosomal
fusion [8,9] and acidification [10], and by altering its me-
tabolism to utilise intracellular substrates such as amino
acids, fatty acids and cholesterol [11-13]. M. tuberculosis
also manipulates the cells’ behaviour by modulating im-
mune signalling [14] and antigen presentation [15], and
by controlling the timing and mode of cell death [16,17].
Many bacterial genes have been identified as involved in
these specific virulence processes [18], both by examin-
ing individual mutants, and by using genome-wide gen-
etic screens [19-22].
M. tuberculosis are also phagocytosed by immature
DCs [23,24], causing them to mature and migrate to
the draining lymph nodes where antigens are presented
to T cells. M. tuberculosis is capable of modulating
much of this maturation cascade [25], by for instance
lowering MHCI and MHCII presentation to CD8+ and
CD4+ T cells respectively [26], and by altering cytokine
profiles [27]. In contrast to macrophages, DCs are
thought to be able to limit intracellular M. tuberculosis
proliferation [28-30], despite M. tuberculosis disrupting
phagosomal trafficking and preventing phagosomal fu-
sion [31]. Transcriptional studies [29,32] indicate that
the DC phagosomal environment has relatively limited
connectivity with host cell recycling and biosynthetic
pathways and so is nutrient limited, particularly with
respect to amino acids and carbon substrates [29].
Other bactericidal stresses such as acidification, and re-
active oxygen and nitrogen species that are associated
with bactericidal activity in activated macrophages ap-
pear to be limited or absent in DCs [29,32,33]. Despite
these studies, we still know relatively little about the
phagosomal DC environment, and the interactions be-
tween it and the bacillus.
In spite of the importance of DCs in the host's re-
sponse to M. tuberculosis infection, there have been no
comprehensive studies of the genetic requirements of M.
tuberculosis to survive inside DCs comparable to those
performed in macrophages [20,34,35]. In this study we
use an M. tuberculosis genome-scale transposon mutant
library, generated in the clinical W-Beijing isolate,
GC1237 [36], to infect human monocyte-derived DCs
and monitored mutant fitness by parallel sequencing.
These data comprehensively describe, for the first time,
the mycobacterial genes required for survival in the DC
and so identify cellular functions and components that
are critical to the interplay between the DC host cell and
M. tuberculosis pathogen.Results and Discussion
Generation of a transposon mutant library in M.
tuberculosis GC1237
A clinical W-Beijing strain of M. tuberculosis, GC1237
[36], was transduced with the Mycomar phage and
plated onto 7H11 to generate a library of approximately
2 × 105 independent insertional mutants. This was a
similar size to equivalent libraries generated previously
in the laboratory strain, M. tuberculosis H37Rv [37].
Subsequent parallel sequencing of the transposon inser-
tion sites and analysis with accumulation curves pre-
dicted that the library contained transposon insertion
into 55,516 of the 62,488 predicted TA dinucleotides of
the M. tuberculosis GC1237 genome (Additional file 1:
Figure S1).
The dynamics of M. tuberculosis infection of DCs
The ability of intracellular M. tuberculosis to proliferate
in DCs remains poorly characterised. Some studies have
described intracellular growth [38-40] in DCs, while
others have reported only static bacterial loads [29,30].
To clarify these contradictory observations, and to place
the results of the library selection in context, we exam-
ined the dynamics of the M. tuberculosis library during
the DC infection.
Dendritic cells (differentiated from donor monocytes,
and with surface markers characteristic of immature
DCs (Additional file 2: Figure S2)) were infected with
the transposon library for 4 h at a multiplicity of infec-
tion (MOI) of 5, resulting in uptake of approximately
8 × 105 cfu per well (a number sufficient to minimise
stochastic sampling errors), and equivalent to 23% of
DCs containing a bacillus (Inset of Figure 1a). During
the first 72 hours the number of DCs decreased to 27%
of their initial number (44% of those in the uninfected
control) (Figure 1b), behaviour similar to that observed
by both Ryan et al. [41] and Abdalla et al. [42]. Total
intracellular bacterial numbers in the DC cultures sug-
gested that there was only limited bacterial growth dur-
ing the infection (Inset of Figure 1a). However when
intracellular M. tuberculosis counts were normalised to
the number of live DC (Figure 1b) the number of M. tuber-
culosis per cell did increase during the first 72 h from an
average of 0.24 cfu per DC to an average of 1.5 cfu per DC
(Figure 1a). These bacterial loads are very similar to those
that have been observed in DCs isolated from M. tubercu-
losis infected mice [4]. This rapid increase in the intracellu-
lar bacterial load was likely due, at least in part, to the
re-uptake of bacilli released from lysed DCs and observed
in the extracellular fraction (Figure 1c). Between day 3 and
day 7 the DC population stabilised and the average bacillary
load per DC did not rise significantly (although donor-to-
donor variability was considerable) indicating only minimal
intracellular bacterial growth (Figure 1a and Figure 1b).
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Figure 1 Dynamics of intracellular and extracellular M. tuberculosis and
their dendritic cell host. The number of (a) intracellular M. tuberculosis per
DC (b) the percentage of viable post-infection DCs and (c) the number
of extracellular M. tuberculosis per DC. Total numbers of bacteria per well
are shown in the plot insets. Error bars are standard errors of the mean
from 5 separate experiments each with different PBMC donors.
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To assess, in parallel, the relative fitness of each mutant
within DCs, DNA from the intracellular M. tuberculosis
mutants was extracted 4 hours, 3 days and 7 days after
infection, and the position and frequency of transposon
inserts determined.Our data identifies a large number of mutants as hav-
ing fitness costs during survival in DCs (Additional file
4). Of the genes identified as non-essential in vitro [43],
mutations in 982 genes had fitness costs after 3 days and
916 after 7 days (Figure 2a); these gene sets correlated
strongly with each other (Spearman’s rank-order correl-
ation = 0.856, p < 1 × 10−6, Figure 2b), indicating that
much of the selection took place during the first 3 days,
with only a few extra genes having fitness effects be-
tween days 3 and 7. This perhaps reflects the stability of
the DC and M. tuberculosis populations during this time
(Figure 1).
These ‘fitness’ associated genes implicate a diverse range
of functions and structures as being important for M. tu-
berculosis survival in DCs, many of which are known viru-
lence factors (p = 4 × 10−8 as reviewed by Forrellad [18])
or have been shown to be important for M. tuberculosis
survival in macrophages [21]. Mutants with fitness costs
included multi-gene loci associated with specific functional
groups such as: the synthesis of lipids e.g. phthiocerol
dimycolates (pDIMs) [44], phenolic glycolipids (PGLs) [45]
and sulfolipids; cholesterol metabolism [46-48] and ESX
systems [49] (Figure 2c and Figure 3). Other functions as-
sociated with fitness are more scattered across the genome,
but included PPE genes, the genes required for nitrate re-
duction and genes involved in the metabolism of methio-
nine/cysteine.
Gene-Nutrient Interactions
Gene-nutrient interaction analysis was used to interpret
our genome-scale dataset [50] and to inform further ex
silico analysis. This powerful method combines the mu-
tant’s intra-cellular ‘fitness’ data with a metabolic model
(GSMN-TB [51]) to make unbiased predictions about
the importance of different metabolic pathways. This
analysis predicted several bacterial nutrients/pathways to
be important during DC infection (Additional file 5)
such as cholesterol catabolism, propionyl and valerate
degradation (which is likely to be associated with the
cholesterol degradation), nitrate reduction, and methio-
nine/cysteine metabolism, as well as several that are well
established as being required for intracellular survival,
e.g. Fe, O2 and CO2. Although powerful, this approach
was somewhat constrained by the redundancy inherent
in M. tuberculosis metabolism and by the wide variety of
theoretical substrates available to M. tuberculosis in
silico and so our interpretation of these outputs remains
cautious. It is perhaps most useful when used to inde-
pendently direct further ex silico analysis.
Cell wall lipids are important for M. tuberculosis survival
in DCs
The lipids of the mycobacterial cell wall are well estab-
lished as important virulence factors both in vivo and in
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Figure 2 Overview of mutant ‘fitness’ during dendritic cell infection. (a) A Euler diagram (Venn diagram with areas proportional to the values) showing
the numbers of mutants with significant fitness costs (p < 0.05) at different times during M. tuberculosis infection of DCs (Additional file 1), (b) a plot of
the ‘fitness’ rank of mutations in individual genes 3 days and 7 days after infection, Spearman’s rank-order correlation ρ= 0.856, p < 1 × 10−6. (c) a genome
plot of the ‘fitness’ of intracellular M. tuberculosis mutants 7 days after infection. Red lines indicate fitness of the gene knockouts 7 days after DC infection.
Black lines are genes assigned as essential in vitro [43] and so excluded from the analysis. Relevant regions of co-functionality are indicated around
the perimeter.
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many of these cell wall lipids are also of primary import-
ance for fitness in DCs. Loci involved in their synthesis
and modification were amongst the genomic regions
most strongly associated with fitness costs.
Mycoserate containing lipids: pDIMs and PGLs. Myco-
serates and the related lipids, phthiocerol dimycolates
(pDIMs) and phenolic glycolipids (PGLs) are recognised as
some of the most important M. tuberculosis virulence fac-
tors, particularly in Beijing strains, such as GC1237, which
can have unusual pDIMs and PGLs that have been equated
with hypervirulence and an ability to modulate cytokine re-
sponses [52,53].
In our DC experiments, mutations known to be asso-
ciated with a loss of pDIM production (Rv2929 to
Rv2942) [44] were strongly associated with fitness cost
both 3 days (p = 5 × 10−7), and 7 days (p = 8 × 10−12) after
the DCs were infected (Figure 3 and Additional file 4).By day 7, all the genes of the pDIM loci [44] except drrA
had a fitness cost when mutated, as well as much of the
Rv0096-Rv0101 loci, another region associated with pDIM
production and virulence in mice [54]. This correlates
with reports of pDIM mutants being attenuated in both
mice [55] and in macrophages [56], phenotypes that have
been associated with an inability to prevent phagosomal
acidification [56]. Observations by Tailleux et al. [32] that
the pDIM region was upregulated during infection of
DCs, further supporting a role for pDIMs in DCs.
Mutation of many of the genes unique to the production
of PGL also had a fitness cost (pkS15/1, Rv2957-2959c
[57] and Rv2962c) at day 3 and day 7 suggesting that PGL,
at least in our GC1237 strain, has a role in M. tuberculosis
survival in DCs (Additional file 4). This is in contrast to
the situation observed in macrophages infected with
H37Rv, where PGL associated attenuation was only ob-
served in pDIM-minus strains [56]. Whether this anomaly
Figure 3 Violin plots of the ‘fitness’ of mutants ordered by functional groups 7 days after dendritic cell infection. Violin plots describing the
distribution of the genes within functional gene groupings ranked by their ‘fitness’ associated p values 7 days after DC infection. Violin plots [139]
are similar to box plots, but use a kernel density estimation of the probability density, similar to a smoothed distribution histogram (light grey
zone), to better illustrate the overall distribution of the data. The probabilities that mutations of the genes of the functional groups had a
decreased intracellular fitness, calculated using the Mann–Whitney U test, are given in brackets. Median values are indicated by the bold black
lines, each gene by smaller dark grey lines, the dashed line represents the median rank for all non-essential genes [43] in the data-set.
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whether it is associated with strain-specific difference in
PGL profiles is difficult to ascertain.
Lipids containing mycolic acids: Cord factor and sulfo-
lipids. Trehalose dimycolate (TDM or cord factor) and
trehalose monomycolate (TMM) are another group of
well characterised M. tuberculosis virulence factors. Cells
with lowered amounts of TMM and TDM are less able
to inhibit lysosomal fusion in macrophages [58] and less
able to grow in macrophages [59]. In this study we ob-
served that TDM is also an important virulence factor in
DCs (Additional file 4).
As cord factor is an essential component of the myco-
bacterial cell wall [60] many of the genes involved in its
synthesis will not be present in the library. However,
some mutants that alter the amount, or change the
structural details, are viable. One such group of genes is
the Ag85 complex, fbpABC, which are all partially re-
dundant and yet all had fitness costs in DCs (Additional
file 4). These genes are involved in the transfer of myco-
lic acid from one TMM to another, to generate TDM
and release trehalose [60]. It has been previously shown
that mutating fbpA and fbpC produces M. tuberculosis
that contains less TDM than wild type strains, that are
less able to evade killing within macrophages, and thatare more susceptible to reactive oxygen (ROS) and react-
ive nitrogen (RNI) species [61]. In other studies fbpA
and fbpC have been shown to be less able to modulate
the expression of MHC-II in DCs and are less able to re-
strict T-cell activation [60,61]. Mutants of fbpD, which
has no TMM/TDM phenotype and is thought not to be
a mycolate transferase [62], did not have fitness costs in
DCs in our study.
Mutations in genes that modify the structure of the
mycolic acids that are bound to the trehalose of TMM
and TDM also had fitness costs in DCs (Additional file 4).
The acylating genes papA3 [63] and pks4, and the mycolic
acid transporter, mmpl10 [64] all had fitness costs after
both 3 and 7 days in DCs. Mutantions that alter or abolish
the methyl, keto and cyclopropyl modifications of these
mycolic acids (mmaA1 [65], mmaA3 [66], mmaA4 [67,68],
umaA [69]) also were less fit in DCs (mma2 and cma2 par-
tially complement one another [65] and did not have a fit-
ness cost when mutated). These mutations are known to
have altered virulence characteristics; mmaA1, mmaA3,
mmaA4 and umaA being highly attenuated and hyper-
inflammatory in macrophages and in murine infection
models [66,67,70].
Sulfolipids, are another group of acylated trehaloses
that are abundant in the mycobacterial cell wall [71].
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sponses is well established [72,73] but there are fewer re-
ports of a direct role in virulence. Gilmore [74] observed
a decrease in intracellular growth in macrophages in sul-
folipid minus mutants, while Passemer et. al. [56] also
noted a loss of virulence in macrophages but only in
pDIM minus M. tuberculosis strains. In our DC studies
the mutations of the genes involved in sulfolipid synthesis
(Rv3820-Rv3826) [75-77]] all had fitness costs (p = 0.008
and 0.007, after 3 and 7 days post-infection, respectively)
as did the sulfolipid transporter, mmpl8 [76], despite the
production of pDIMs (Figure 3 and Additional file 4).
Gene nutrient interaction analysis also identified cysteine/
methionine metabolism as important for survival in DCs
(p = 0.019 after 7 days; Figure 3 and Additional file 4). Al-
though this may be associated with a requirement for
amino acid synthesis, this seems unlikely as it is thought
that methionine is available to M. tuberculosis in vivo [78].
However, a functional sulphur metabolism would be re-
quired for the supply of sulphur from such amino acid
substrates to sulfolipid synthesis and this may in part ex-
plain the fitness costs associated with cysteine/methionine
metabolism. Taken together, these data clearly show that
in DCs, sulfolipids have an important and as yet, not fully
elucidated, role even when pDIMs are present.
Lipids: PIM, LM and LAM. Phosphatidylinositol man-
nosides (PIM), lipomannan (LM) and lipoarabinomannans
(LAM) are also essential components of the M. tubercu-
losis cell wall and so genes required for their synthesis
[79,80] will not be present in the library. Both PIM and
LAM have been implicated in survival in macrophages, by
amongst other mechanisms, the inhibition of phagolysoso-
mal fusion [81], and the modulation of both cytokine re-
sponses and of the phagosomal maturation process [25].
Much of this activity is thought to require LAM with an
intact mannose cap [82], although cap-less mutants
(ΔRv1635c) have been reported to have an unaltered wild-
type phenotype in murine macrophages and in vivo [83].
In our human DC experiments, mutants predicted to re-
sult in a non-mannose capped LAM (Rv2181, Rv1635c,
Rv1565c) all had a fitness cost both 3 days and 7 days
post-infection (Additional file 4). This is consistent with
studies showing that M. tuberculosis binding to human
DCs involves interaction of manLAM with the receptor
DC-SIGN [29,84].
Cholesterol side chain catabolism contributes to fitness in
DCs
Cholesterol is both an important nutrient for intracellu-
lar M. tuberculosis and a critical part of the host cell’s re-
sponse to M. tuberculosis [85]. As such, the catabolism
of cholesterol has multiple functions during macrophage
infection. It provides propionyl-coA precursors for the
synthesis of pDIM [86,87] and the sulfolipid, SL-1 [88]via methyl malonyl-coA. It can be used to supply carbon
to central metabolism of M. tuberculosis as succinate
and pyruvate [86]. Finally, the degradation of host chol-
esterol can be involved in the modulation of intracellular
trafficking and immune signalling [89-91]. Prior to this
present study, it was not known which of these func-
tions, if any, were important during DC infection, al-
though cholesterol catabolism genes and the associated
kstR regulon [92] were known to be upregulated [32].
Our data provides evidence for the importance of chol-
esterol catabolism during DC infection (p = 0.05, Fig-
ure 2c and Figure 3), an interpretation confirmed by the
gene-nutrient interaction analysis (Additional file 5). How-
ever fitness costs were mainly associated with mutants of
the mce4 cholesterol transporting operon [47](p = 0.0026
after 7 days), genes involved in early steps in cholesterol ca-
tabolism eg choD, Rv1106c, kstD, and genes involved in
side chain degradation [48,93] (Figure 3, Additional file 4,
Biocyc pathway p = 0.0002 after 7 days), notably the igr re-
gion [94,95]. Fitness costs were not apparent for mutations
in genes involved in sterol ring degrading pathways, such
as hsaA-G (although several of these are known to have
only minimal effects on growth in cholesterol e.g. hsaEFG
[48], and the genes of the kstR2 regulon [46,96].
The fitness costs associated with disruption of choles-
terol side chain degradation pathways and the importance
of mycolic acid synthesis during DC infection together
suggests that a critical function of cholesterol degradation
is to supply propionyl-CoA for the synthesis of pDIM and
SL-1. Both which are virulence factors that we have shown
are important for survival in DCs. However, an absolute
requirement for cholesterol derived carbon seems unlikely,
as the genes required for the release of carbon from the
sterol component of cholesterol [48] did not have fitness
costs. There is however evidence for a role for cholesterol
catabolism in modulating the DC response to M. tubercu-
losis. Consistent with previous findings in macrophages,
our data indicates a fitness cost for mutations in choD.
ChoD is an extracellular cholesterol oxidase that when
mutated does not abolish the M. tuberculosis ability to
grow on cholesterol, but does attenuate M. tuberculosis in
macrophages via inhibition of TLR2 signalling [91] and re-
duction of iNOS and ROS responses [89].
Genes that prevent phagosomal maturation in
macrophages also have a fitness cost in DCs
M. tuberculosis residing in both DCs and macrophages
are contained within phagosomes, whose development
has been arrested at an early stage in the endocytic path-
way [29]. However macrophage and DC phagosomes do
differ in other respects: DC mycobacterium-containing
phagosomes undergo only limited acidification and have
more restricted connectivity to other parts of the endo-
cytic system [29,31]. Although we do not assay for a
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studies have demonstrated that in general M. tubercu-
losis mutants with an abrogated ability to inhibit macro-
phage phagosomal maturation are also attenuated for
intracellular survival [34]. We compared our intra-DC
fitness data with published data-sets generated using
genome-wide screens for mutants that are defective in
their ability to inhibit murine macrophage phagosome
maturation [34,97,98]. We observed that many of these
phagosome-control mutants also had reduced fitness in
DCs at both 3 and 7 days post-infection (p = 0.058
/0.0027 [34,97] and p = 0.016/0.0023 [34,97] respectively)
(Figure 3 and Additional file 4). Similarly, many genes
recognised individually as involved in modulating phago-
somal maturation e.g. sapM [99], PE_PGRS62 [100],
PE_PGRS30 [101], eis [102] also had fitness costs. Finally,
many of the virulence associated functions and structures
such as cell-wall lipids and LAM [103], that we have
already identified as important for fitness in these DCs
are known to be involved in preventing phagosomal
maturation, properties which may in part explain the
intra-DC fitness costs of mutating these genes. We con-
clude that despite the difference between DC and
macrophage phagosomes, control of phagosome-
lysosome fusion remains as important for M. tubercu-
losis fitness in human DCs as it is in macrophages and
is modulated using similar mechanisms.
A novel role for ESX transport systems in DC
There are five ESX/type VII secretion systems/regions in
the M. tuberculosis genome, of which two are essential
for in vitro growth on microbiological medium (ESX-3
and ESX-5) [104,105]. We show that mutations, particu-
larly in the pore-forming components [49], of the other
three ESX systems (ESX-1, ESX-2 and ESX-4) all had fit-
ness costs for growth in human DCs (p = 0.0007, 0.0005
and 0.042 respectively after 7 days, Figure 3 and Additional
file 4). ESX-1 is the best characterised of these systems and
is involved in the export of the classic virulence factors,
ESAT-6, CFP-10 and many Esp proteins. ESX-2 and ESX-4
are less well studied and until now have not been recog-
nised as virulence determinants [106].
Unexpectedly, the intra-DC fitness cost associated
with loss of the ESX-1 secretion apparatus were not
found to be associated with mutants of the canonical
ESX-1 substrates, ESAT-6 and CFP10 (Figure 3 and
Additional file 4). This discrepancy, which has been ob-
served previously in mice [107,108], implies an add-
itional function for the ESX-1 system that is important
for survival and virulence in DCs. Work by Joshi et al.
[109] with an eccA1 mutant of M. marinum supports
such a conclusion, with evidence that ESX-1 is not only
required for the export of ESAT-6 type proteins, but also
for the export of enzymes involved in the synthesis ofmycolic acids, pDIMs and PGLs e.g. Pks13, KasB, KasA,
MmaA4, Pks5, Mas, Pks15/1, PpsD, and PpsE. This links
with our findings that production of wild-type amounts of
these lipids is important for survival in DCs. Many PPE
genes are also thought to be exported by ESX systems
[49,110]. Indeed, in M. marinum ESX-5 has been shown
to export many of the PPE proteins [111,112]. These PPE
genes are defined by a proline-glutamate-glutamate motif,
but may have varying roles in M. tuberculosis physiology
and virulence and remain poorly characterized (for a
review see Akhter et al., 2012 [113]). This study shows
strikingly that many of these PPE proteins are important
for fitness in the human DC with over half of the anno-
tated PPE mutants lost from the library by day 7 (p =
1.5 × 10−6), including many of the PPE genes chromosom-
ally and functionally associated with ESX-5 in M. mari-
num (PPE28, PPE29, PPE30, PPE31, PPE32 and PPE33)
[111]. It seems reasonable to extrapolate that in M. tuber-
culosis, ESX-5 may also secrete these PPE proteins and po-
tentially many of the numerous other PPE proteins that
we have shown are important for intra-DC virulence. Thus
we believe ESX-5 is an important virulence factor in
M. tuberculosis.
M. tuberculosis responses to oxidative and nitrosative
stress
Human DCs are thought to produce less ROS than mac-
rophages in response to M. tuberculosis infection [32,114]
and are more resistant to ROS associated apoptosis. M. tu-
berculosis resistance to ROS is mediated via a range of
genes and cellular components, such as the cell wall,
which scavenges free radicals, and protein and DNA repair
systems, which are actively involved in withstanding ROS
stress [115]. Many genes associated with ROS resistance
do have fitness costs in DCs (Additional file 4): genes of
methionine/cysteine metabolism (as identified by gene-
nutrient interaction analysis) [116]; glutamyl-cysteine lig-
ase; Rv1806 to Rv1809 (PPE20, PPE30-33) [117]; as well as
many genes involved in the synthesis of the cell wall com-
ponents such as LAM, PGL and mycoseric acid. However
it is difficult to distinguish a ROS specific role for many of
these pleiotropic genes. Specific evidence for significant
ROS associated fitness costs in DCs is also difficult to
equate with the lack of fitness cost for genes such as those
of the oxidized guanine (GO) DNA repair system [118],
lsr2 [88], ahpC [119], or mycothiol pathways [120,121],
making predictions as to the role of ROS in M. tubercu-
losis infection of DCs unclear, but suggesting that it does
not represent a dominant antimicrobial mechanism.
The role of nitrogen radicals in human DCs is also not
well established. Murine DCs are known to produce a
nitrosative burst upon M. tuberculosis infection, but there
is less evidence for an equivalent response in humans
[32,122]. We find that many of the genes that have been
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phages are also important during DC infection e.g. fbiC,
Rv2115c, Rv2097 [123], the nucleotide excision repair sys-
tem encoded by uvrABCD1D2 [124] and nitrate reductase
associated genes (narG, narH, narI, narK1, narK2, narX,
nirB, p = 0.0021, Figure 3 and Additional file 4). In macro-
phages, nitrate reductase is important for many of the M.
tuberculosis responses to reactive nitrogen. An active ni-
trate reductase in the presence of NO, has been shown to
promote M. tuberculosis growth [125], to be a source of
nitrite (which could then acts as signal molecule forM. tu-
berculosis) [122] or potentially disrupt NO signalled apop-
tosis [126]. Without nitrate reductase M. tuberculosis is
more susceptible to both acid [127] and peroxide stress
[128]. Our data imply that NO, or at least nitrate, is indeed
present in the phago-lysosome of human DCs. This re-
quirement for nitrate reductase is unlikely to be associated
with resistance to acid (at least in DCs) as has been de-
scribed for macrophages [127] but more likely relates to its
other growth promoting roles such as providing an alterna-
tive electron acceptor, making available a source of meta-
bolic nitrogen, or as a mechanism of preventing apoptosis.
Conclusions
The ability to survive within DCs is integral to the ability
of M. tuberculosis to manipulate and on occasions usurp
the host's immune response. As such the genetic require-
ments for these processes represent importantM. tubercu-
losis virulence components. By using high-throughput
analysis of transposon libraries we have produced a com-
prehensive genome-scale assessment of the genetic re-
quirements of a clinical M. tuberculosis W-Beijing isolate,
GC1237, for survival in DCs. Such an approach connects
gene and function, allowing analysis at multiple scales:
from single loci, regulon, metabolic pathway, and even
whole cell, rather than on the gene-by-gene basis pro-
duced by more conventional gene knockout strategies in-
volving one or two mutants. Such a strategy has been used
previously with the laboratory strain M. tuberculosis
H37Rv, to successfully describe the genes required for a
range of virulence related environments: in vitro growth
[48]; infection of mice [37]; survival in murine macro-
phage, human cell lines and murine bone marrow derived
macrophages [21]; and for the ability to inhibit phagosome
maturation [22,34,97,98].
Our data shows that the survival of M. tuberculosis
within human DCs requires a large number of genes
(see Figure 4 for a summary), many of which have previ-
ously been recognised as also being important during
the invasion and survival of macrophages. Perhaps the
best characterised of these are the genes involved in the
synthesis, transport and modification of cell wall lipids.
These lipids are clearly very important to the ability of
M. tuberculosis to survive within DCs. Our datademonstrates that not only are the well-established viru-
lence associated lipids important such as pDIM and cord
factor, but also lipids that had previously only been as-
cribed secondary roles such as PGL and sulfolipids [56].
These secondary lipids have long been recognised as
modulators of macrophages when added exogenously
[74], or associated with modulating cytokine production
[52,53] and virulence in mice, but have not previously
been shown to have a direct effect on intracellular viru-
lence of M. tuberculosis [56] and may be especially im-
portant during DC infection. The apparent requirement
for M. tuberculosis GC1237 to have functional choles-
terol catabolism and sulphur metabolism when in DCs
may also be linked to the supply of the metabolites re-
quired for the synthesis of these cell wall lipids, although
roles in nutrition or immune modulation cannot be
ruled out.
In macrophages, cell wall lipids act, in part, by modu-
lating the phagosomal environment. Despite differences
in the physiology and cell biology of macrophage and DC,
mycobacterial modulation of the phagosome remains im-
portant in DCs, with similarities between genes required
for survival in DCs and groups of genes identified as
required for phagosomal modulation in macrophages. The
ESX-1 secretion system is well established as a fundamental
virulence mechanism of M. tuberculosis, being involved in
host-pathogen interactions including phagosome escape
and cytotoxicity. Here, we demonstrate a role during DC
infection for not only ESX-1 but also ESX-2 and ESX-4,
and a requirement for PPE genes, which implicates ESX-5
as also having a direct role in mycobacterial pathogenesis.
The functions of the abundant and characteristic PPE gene/
protein family have remained elusive but we show, for the
first time, that the intra-DC environment represents a
powerful non-redundant selection for their maintenance in
the genome. We also identify important roles for sulphur
and nitrogen metabolism. Cysteine/methionine metabolism
is an important fitness determinant, possibly related to re-
sistance to reactive species or to the production of sulfoli-
pids. Nitrate reductase was also important during survival
within DCs, and again the mechanism is unclear, but resist-
ance to reactive nitrogen intermediates, nitrogen acquisi-
tion, or a role in intercellular signalling would seem likely
candidates.
Clearly, many M. tuberculosis intracellular virulence
mechanisms are common to both macrophages and
DCs. This may reflect the close relationship between the
myeloid DC and the macrophage which represent differ-
ent but related cell types within a single mononuclear
phagocytic system. However, we also identify novel DC
virulence mechanisms that are important in human DC
infection but which are either absent or have been over-
looked in macrophages. Further investigations into the
mechanisms that underlie the importance of these
Figure 4 Summary of the major cellular components and processes that are associated with fitness costs during M. tuberculosis survival
within DC.
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understanding of the nature of the inter-relationship be-
tween host and pathogen during pathogenesis.
Methods
M. tuberculosis culture and library construction
M. tuberculosis GC1237, a W-Beijing strain [36] was
routinely grown at 37°C on Middlebrook 7H11 plates
containing 10% OADC and 0.2% glycerol or in 7H9
media containing 10% ADC, 0.2% glycerol and 0.05%
Tween 80®. M. tuberculosis were enumerated by plating
10 μl drops of serially diluted culture onto 7H11 plates.
M. smegmatis mc2 were grown in Nutrient Broth II with
0.2% glycerol and 0.05% Tween 80® or on solid Nutrient
Broth II media with 0.2% glycerol. The temperature sen-
sitive phage, phAE87 [129] containing pMycoMar [130]
was prepared by adding an aliquot of late log phase M.
smegmatis to Nutrient Broth II top agar with an appropri-
ate number of phage such that the resultant plaques were
touching. After 3 days at 30°C the top agar was scraped
from the plates and shaken with an equal volume of MP
buffer (150 mM NaCl, 50 mM Tris, 10 mM MgSO4, 2 mM
CaCl2, pH 7.4), the preparation was centrifuged, the super-
natant passed through a 0.22 μM filter, and the phage enu-
merated. The M. tuberculosis library was prepared by
washing an M. tuberculosis GC1237 culture, of approxi-
mate OD600 1.0 with an equal volume of MP buffer and
resuspending in 0.1 volumes of phAE87 at an multiplicity
of infection (MOI) of between 10–100, incubating at 37°C
for 4 h and plating on 7H11 media containing kanamycinat 30 μg ml−1. The resultant library was scraped from the
plates and stored at −80°C in 10% glycerol.
Generation of monocyte derived dendritic cells
Monocytes were isolated from leukocyte cones (National
Health Service Blood and Transplant, UK), from 5 differ-
ent donors. For each, the cones were diluted with PBS
containing 2 mM EDTA, layered onto HistoPacque®-1077,
centrifuged at 400 × g for 30 min and allowed to come to
rest without braking. Monocytes were purified from the
resulting buffy coat using CD14 Microbeads (Miltenyi,
Bisley, UK) as recommended by the manufacturers.
Approximately 1 x 107 monocytes were differentiated
into DCs in 75 cm2 flasks incubated at 37°C with 5%
CO2. DCs were grown in RPMI 1640 containing Gluta-
Max™ (Invitrogen, Paisley, UK), supplemented with 10% Fetal
Calf Serum (FCS) and 10 ng ml−1 GM-CSF (PeproTech,
London, UK) and 20 ng ml−1 IL-4 (PeproTech). After
6 days the differentiated cells were washed three times
in PBS by centrifugation, resuspended in fresh growth
media and 3 × 106 cells per well cultured in 6 well tissue
culture plates.
Flow Cytometry
DCs were washed in FACS buffer (PBS containing
5 mM EDTA, 1% FCS, 0.05% sodium azide). The cells
were resuspended in FITC or PE conjugated antibody
for CD14, CD83, CD86, CD1a or appropriate isotype
controls diluted 1:100 or 1:20 with FACS buffer. The
cells were incubated on ice for 30 min and then washed
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maldehyde in PBS. Samples were run on FACS Canto™
(BD Biosciences, Oxford, UK) recording 10,000 events.
Infection of dendritic cells with M. tuberculosis
Each DC preparation was infected with a previously fro-
zen aliquot of the M. tuberculosis library cultured for
24 h in 7H9 with ADC but without Tween 80®. Broths
were centrifuged and resuspended in DC growth media,
and passed multiple times through a 26G needle to dis-
perse clumps. The inocula concentration was estimated
by measuring optical density at 600 nM and diluted in
DC growth media to give a MOI of 5. The M. tubercu-
losis were added to the DCs and the infection incubated
at 37°C for 4 h. Control wells contained either no M. tu-
berculosis or no DCs.
After the infection, M. tuberculosis that were not inter-
nalized were removed by washing the wells three times
with DC growth medium. Planktonic DCs in these first
washes were then separated from the bacteria by com-
bining the supernatants, and centrifuging at 500 × g for
5 min three times, each time removing the supernatant
and resuspending the cell pellet in fresh DC growth
medium. The supernatants were combined and the
“extracellular” M. tuberculosis recovered by centrifuging
at 3500 × g for 5 min and enumerated by plating on
7H11 and counting colony forming units.
The intracellular fraction was prepared by resuspend-
ing the planktonic cell pellet from the extracellular prep-
aration in 0.1% Triton X-100® and adding this back to
the adherent cells remaining in the well. This lysate was
centrifuged at 3500 × g for 5 min, the bacterial pellet re-
suspended in an appropriate volume, enumerated and
the remainder spread on plates to recover the library for
DNA purification and TnSeq analysis (see below). For
DC counts, the growth media was removed from a well
and centrifuged at 500 × g to give a cellular pellet. Ver-
sene™ (Invitrogen) was added to the well and the plate
incubated at 37°C for 10 min. The Versene™ was re-
moved and used to resuspend the cellular pellet, and live
and dead cells counted using a Trypan Blue exclusion
assay. Infections were sampled immediately after wash-
ing (4 hours), after 3 days and after 7 days. Recovered li-
braries were scraped from the plates and stored at −80°C
in 10% glycerol.
DNA purification and preparation
DNA was extracted from recovered libraries from three
of the infections. An aliquot of each recovered library
was added to a lysing matrix B tube (MPBiomedicals,
Loughborough, UK) containing 25:24:1 phenol:chlorofor-
m:isoamyl alchohol and TE, and mechanically disrupted
in a Fastprep™ FP120 (MPBiomedicals) at setting 4 for
30 sec. The preparation was centrifuged at 12,000 × g for5 min, and the supernatant washed twice with chloroform,
and precipitated with × 0.7 volumes isopropanol and × 0.1
volumes 3 M sodium acetate. DNA was resuspended in
water and sheared by sonicating 3 times for 30 sec each
(1 sec on/1 sec off) with a VibraCell® VC300 and a 6 mm
probe. Sheared DNA was repaired by incubating with 100
U μl−1 T4 DNA polymerase (Promega, Southampton,
UK), 50 mU μl−1 Klenow (Promega), 100 mU μl−1 poly-
nucleotide kinase (New England Biolabs, Hitchin, UK),
2 mM dNTPs all in × 1 T4 DNA ligase buffer (Promega)
for 30 min at 20°C. Repaired DNA was purified using
QIAquick™ columns (Qiagen, Crawley, UK), and end la-
belled with A nucleotides by incubating with 0.25 U μl−1
Klenow, 0.2 mM dATP in × 1 Klenow buffer (Promega)
for 30 min at 37°C and purified on MiniElute™ PCR purifi-
cation kits.
Transposon amplification
A linker was generated by annealing oligonucleotides
linker1 and linker2 (Additional file 3: Table S2a) at equi-
molar concentrations in 50 mM NaCl, 5 mM Tris,
0.5 mM EDTA, pH 8 by heating the mix to 95°C for 2 min
and then cooling for approximately 1 h to 20°C. The linker
was annealed to the sheared genomic DNA at eqimolar ra-
tios of fragment ends using T4 DNA ligase incubated at
16°C for 18 h. The fragments were PCR amplified with
0.2 μM PCR-linker primer and either 0.2 μM primer PCR-
MarinerA or PCR-MarinerB (Additional file 3: Table S1),
using 0.02 U μl−1 KOD Hot Start DNA polymerase
(Novagen, Feltham, UK), ×1 KOD buffer, 0.2 mM dNTPs
and 1.5 mM MgCl2. Conditions were 94°C for 2 min,
followed by 5 cycles of 95°C for 30 sec, 69°C for 10 sec,
70°C for 30 sec, followed by another 5 cycles with an an-
nealing temperature of 67°C, followed by 20 cycles with an
annealing temperature of 65°C. Products sized between
250–500 bp were cut from an agarose gel, cleaned with
QIAquick columns, and equal amounts of each PCR prod-
uct (MarinerA and MarinerB) combined and amplified with
primers PCR2-linker and PCR2-Mariner as before but with
cycle conditions of 94°C for 2 min, followed by 9 cycles of
95°C for 30 sec, 57°C for 10 sec and 70°C for 30 sec. Frag-
ment sizes were assessed and products quantified with a
BioAnalyzer 2100 (Agilent). The indexed products from dif-
ferent samples were combined, spiked with 50% PhiX and
sequenced on an Illumina® 2000 HiSeq™ machine, with a
single index and a single read of 100 cycles.
Sequence analysis and statistical analysis
Sequence reads were assigned to samples according to their
indices and aligned to the GC1237 genome using Bowtie2
[131]. Transposon TA junctions were identified from se-
quence reads that contained a fragment of GC1237 genome
preceded by the terminal-end of the transposon sequence
(5’ CGGGGACTTATCAGCCAACCTGT, 2 mismatches
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paring transposon frequencies between time points (be-
tween 4 h and 3 days, and 4 h and 7 days) using a method
based upon the logistic distribution of the difference of two
extreme value random variables [132]. This approach de-
pends upon the difference in length of the two longest
transposon-free runs at two time points with null hypoth-
esis of zero difference. Values for the three repeats were
combined using Fisher’s combined probability test as
reviewed by Loughin, 2004 [133], and a value of p < 0.05
was considered to represent a significant loss of fitness.
Correlations between the library at different time points
were assessed using the Spearman’s rank order coefficient.
The significance of gene group enrichments was deter-
mined using the Mann–Whitney U test (Wilcoxon rank-
sum test).
Accumulation curves
To determine the library coverage the number of unique
TA sites mutated was plotted against the number of in-
sertions sequenced. Asymptotes were calculated by fit-
ting Michaelis-Menten curves to the plots.
Gene Nutrient Interactions
Gene-nutrient interaction (GNI) analysis, as developed
by Idit et al. [50], aims to describe the relationship be-
tween gene essentiality and the presence or absence of
nutrients in the growth environment. Using the ap-
proach, the 101 nutrients from the GSMN-TBM. tuber-
culosis metabolic model [51] were randomly sampled to
generate 1.17 × 106 in silico growth media. Flux balance
analysis was carried for each growth media to identify
essential genes. A gene was considered essential if the
drop in the growth rate after its knockout was more
than 20 %. Positive/negative GNI were identified when a
nutrient was present/absent in a significantly number of
media under which the gene was essential, as estimated
by calculating a p-value based on the hypergeometric
distribution. The calculation above has been imple-
mented as an extension to Surrey FBA software [134]
and is available on request.
Availability of supporting data
All raw sequence read files have been submitted to
the Sequence Read Archive of the National Center
for Biotechnology Information under SRA Study ac-
cession, SRP057496.
Additional files
Additional file 1: Figure S1. An accumulation curve of the transposon
insertion sites in the M. tuberculosis library.
Additional file 2: Figure S2. Flow cytometry data of surface markers of
differentiated PBMCs.Additional file 3: Table S1. A list of primers used in this study.
Additional file 4: An Excel file containing p values associated with
the fitness during survival in DC, arranged by functional group.
Additional file 5: An Excel file containing the results of gene
nutrient-interaction analysis.
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